MedPath

Study to Assess Efficacy of Tacrolimus + Methotrexate Versus Placebo + Methotrexate in Treatment of Rheumatoid Arthritis

Phase 3
Completed
Conditions
Rheumatoid Arthritis
Registration Number
NCT00036153
Lead Sponsor
Astellas Pharma Inc
Brief Summary

The purpose of this study is to evaluate the efficacy of the combination of tacrolimus + methotrexate compared to methotrexate alone in the treatment of the signs and symptoms of rheumatoid arthritis over 6 months in patients with partial response to methotrexate.

Detailed Description

This is a Phase III, 6 month randomized, double-blind, placebo controlled multi-center study with a 6 month open-label extension. Patients will be randomized to the tacrolimus + methotrexate arm or the placebo + methotrexate arm in a ratio of 2:1. Patients who complete the 6-month double-blind phase will be eligible to enroll in the open-label phase of the study.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
210
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (44)

University of Alabama at Birmingham

🇺🇸

Birmingham, Alabama, United States

Rheumatology Associates of North Alabama

🇺🇸

Huntsville, Alabama, United States

Radiant Research, Pharmaceutical Clinical Trials Division

🇺🇸

Scottsdale, Arizona, United States

Boling Clinical Trials

🇺🇸

Rancho Cucamonga, California, United States

San Diego Arthritis & Osteoporosis Medical Clinic

🇺🇸

San Diego, California, United States

Pacific Arthritis Center and Medical Group

🇺🇸

Santa Maria, California, United States

Arthritis Associates of CT

🇺🇸

Danbury, Connecticut, United States

Stamford Therapeutic Consortium

🇺🇸

Stamford, Connecticut, United States

Center of Rheumatology, Immunology & Arthritis

🇺🇸

Ft. Lauderdale, Florida, United States

Arthritis Center

🇺🇸

Palm Harbor, Florida, United States

Scroll for more (34 remaining)
University of Alabama at Birmingham
🇺🇸Birmingham, Alabama, United States
© Copyright 2025. All Rights Reserved by MedPath